197 related articles for article (PubMed ID: 25845412)
1. Safety of vitamin K antagonist treatment for splanchnic vein thrombosis: a multicenter cohort study.
Riva N; Ageno W; Poli D; Testa S; Rupoli S; Santoro R; Lerede T; Piana A; Carpenedo M; Nicolini A; Ferrini PM; Tosetto A; ;
J Thromb Haemost; 2015 Jun; 13(6):1019-27. PubMed ID: 25845412
[TBL] [Abstract][Full Text] [Related]
2. Antithrombotic treatment with direct-acting oral anticoagulants in patients with splanchnic vein thrombosis and cirrhosis.
De Gottardi A; Trebicka J; Klinger C; Plessier A; Seijo S; Terziroli B; Magenta L; Semela D; Buscarini E; Langlet P; Görtzen J; Puente A; Müllhaupt B; Navascuès C; Nery F; Deltenre P; Turon F; Engelmann C; Arya R; Caca K; Peck-Radosavljevic M; Leebeek FWG; Valla D; Garcia-Pagan JC;
Liver Int; 2017 May; 37(5):694-699. PubMed ID: 27778440
[TBL] [Abstract][Full Text] [Related]
3. Outcomes of long-term anticoagulant treatment for the secondary prophylaxis of splanchnic venous thrombosis.
Serrao A; Merli M; Lucani B; Aprile F; Fiori L; Gioia S; Breccia M; Riggio O; Chistolini A
Eur J Clin Invest; 2021 Jan; 51(1):e13356. PubMed ID: 33180323
[TBL] [Abstract][Full Text] [Related]
4. Anticoagulation and Vessel Recanalization in Cirrhotic Patients with Splanchnic Vein Thrombosis: A Multidisciplinary "Real Life" Experience.
Rupoli S; Fiorentini A; Morsia E; Svegliati-Baroni G; Micucci G; Maroni L; Garvey KB; Fiorentini A; Riva A; Da Lio L; Benedetti A; Offidani M; Olivieri A; Giuseppe T
Vasc Health Risk Manag; 2021; 17():619-629. PubMed ID: 34594107
[TBL] [Abstract][Full Text] [Related]
5. Long-term Clinical Outcomes of Splanchnic Vein Thrombosis: Results of an International Registry.
Ageno W; Riva N; Schulman S; Beyer-Westendorf J; Bang SM; Senzolo M; Grandone E; Pasca S; Di Minno MN; Duce R; Malato A; Santoro R; Poli D; Verhamme P; Martinelli I; Kamphuisen P; Oh D; D'Amico E; Becattini C; De Stefano V; Vidili G; Vaccarino A; Nardo B; Di Nisio M; Dentali F
JAMA Intern Med; 2015 Sep; 175(9):1474-80. PubMed ID: 26168152
[TBL] [Abstract][Full Text] [Related]
6. Splanchnic vein thrombosis and variceal rebleeding in patients with cirrhosis.
Amitrano L; Guardascione MA; Scaglione M; Menchise A; Martino R; Manguso F; Lanza AG; Lampasi F
Eur J Gastroenterol Hepatol; 2012 Dec; 24(12):1381-5. PubMed ID: 23114742
[TBL] [Abstract][Full Text] [Related]
7. Clinical course of patients with symptomatic isolated superficial vein thrombosis: the ICARO follow-up study.
Barco S; Pomero F; Di Minno MND; Tamborini Permunian E; Malato A; Pasca S; Barillari G; Fenoglio L; Siragusa S; Di Minno G; Ageno W; Dentali F
J Thromb Haemost; 2017 Nov; 15(11):2176-2183. PubMed ID: 28871623
[TBL] [Abstract][Full Text] [Related]
8. Clinical history and antithrombotic treatment of incidentally detected splanchnic vein thrombosis: a multicentre, international prospective registry.
Riva N; Ageno W; Schulman S; Beyer-Westendorf J; Duce R; Malato A; Santoro R; Poli D; Verhamme P; Martinelli I; Kamphuisen P; Dentali F;
Lancet Haematol; 2016 Jun; 3(6):e267-75. PubMed ID: 27264036
[TBL] [Abstract][Full Text] [Related]
9. Anticoagulant therapy in patients with non-cirrhotic portal vein thrombosis: effect on new thrombotic events and gastrointestinal bleeding.
Spaander MC; Hoekstra J; Hansen BE; Van Buuren HR; Leebeek FW; Janssen HL
J Thromb Haemost; 2013 Mar; 11(3):452-9. PubMed ID: 23289370
[TBL] [Abstract][Full Text] [Related]
10. Harmful and Beneficial Effects of Anticoagulants in Patients With Cirrhosis and Portal Vein Thrombosis.
La Mura V; Braham S; Tosetti G; Branchi F; Bitto N; Moia M; Fracanzani AL; Colombo M; Tripodi A; Primignani M
Clin Gastroenterol Hepatol; 2018 Jul; 16(7):1146-1152.e4. PubMed ID: 29066371
[TBL] [Abstract][Full Text] [Related]
11. Splanchnic vein thromboses associated with myeloproliferative neoplasms: An international, retrospective study on 518 cases.
Sant'Antonio E; Guglielmelli P; Pieri L; Primignani M; Randi ML; Santarossa C; Rumi E; Cervantes F; Delaini F; Carobbio A; Betti S; Rossi E; Lavi N; Harrison CN; Curto-Garcia N; Gisslinger H; Gisslinger B; Specchia G; Ricco A; Vianelli N; Polverelli N; Koren-Michowitz M; Ruggeri M; Girodon F; Ellis M; Iurlo A; Mannelli F; Mannelli L; Sordi B; Loscocco GG; Cazzola M; De Stefano V; Barbui T; Tefferi A; Vannucchi AM
Am J Hematol; 2020 Feb; 95(2):156-166. PubMed ID: 31721282
[TBL] [Abstract][Full Text] [Related]
12. Antithrombotic treatment of splanchnic vein thrombosis: results of an international registry.
Ageno W; Riva N; Schulman S; Bang SM; Sartori MT; Grandone E; Beyer-Westendorf J; Barillari G; Di Minno MN; Dentali F;
Semin Thromb Hemost; 2014 Feb; 40(1):99-105. PubMed ID: 24381147
[TBL] [Abstract][Full Text] [Related]
13. Current outcome of portal vein thrombosis in adults: risk and benefit of anticoagulant therapy.
Condat B; Pessione F; Hillaire S; Denninger MH; Guillin MC; Poliquin M; Hadengue A; Erlinger S; Valla D
Gastroenterology; 2001 Feb; 120(2):490-7. PubMed ID: 11159889
[TBL] [Abstract][Full Text] [Related]
14. Optimal timing of vitamin K antagonist resumption after upper gastrointestinal bleeding. A risk modelling analysis.
Majeed A; Wallvik N; Eriksson J; Höijer J; Bottai M; Holmström M; Schulman S
Thromb Haemost; 2017 Feb; 117(3):491-499. PubMed ID: 28004062
[TBL] [Abstract][Full Text] [Related]
15. How to manage splanchnic vein thrombosis in patients with liver disease.
Riva N; Ageno W
Hematology Am Soc Hematol Educ Program; 2023 Dec; 2023(1):281-288. PubMed ID: 38066910
[TBL] [Abstract][Full Text] [Related]
16. Clinical course of isolated distal deep vein thrombosis in patients with active cancer: a multicenter cohort study.
Dentali F; Pegoraro S; Barco S; di Minno MND; Mastroiacovo D; Pomero F; Lodigiani C; Bagna F; Sartori M; Barillari G; Mumoli N; Napolitano M; Passamonti SM; Benedetti R; Ageno W; Di Nisio M
J Thromb Haemost; 2017 Sep; 15(9):1757-1763. PubMed ID: 28639418
[TBL] [Abstract][Full Text] [Related]
17. Bleeding risk in very old patients on vitamin K antagonist treatment: results of a prospective collaborative study on elderly patients followed by Italian Centres for Anticoagulation.
Poli D; Antonucci E; Testa S; Tosetto A; Ageno W; Palareti G;
Circulation; 2011 Aug; 124(7):824-9. PubMed ID: 21810658
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of direct oral anticoagulants and vitamin K antagonists in mesenteric venous thrombosis.
Salim S; Ekberg O; Elf J; Zarrouk M; Gottsäter A; Acosta S
Phlebology; 2019 Apr; 34(3):171-178. PubMed ID: 29848218
[TBL] [Abstract][Full Text] [Related]
19. Risk of Bleeding and Thrombosis in Patients 70 Years or Older Using Vitamin K Antagonists.
Kooistra HA; Calf AH; Piersma-Wichers M; Kluin-Nelemans HC; Izaks GJ; Veeger NJ; Meijer K
JAMA Intern Med; 2016 Aug; 176(8):1176-83. PubMed ID: 27379731
[TBL] [Abstract][Full Text] [Related]
20. Outcomes during anticoagulation in patients with symptomatic vs. incidental splanchnic vein thrombosis.
Tufano A; Ageno W; Di Micco P; Niglio A; Rosa V; Ballaz A; Braester A; Rubio CM; Isern V; Imbalzano E; Monreal M;
Thromb Res; 2018 Apr; 164():69-74. PubMed ID: 29499439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
